UK Imposes New Limits On Deferring Registration Of Clinical Trials
Executive Summary
The UK is changing its policy for deferring the registration of a clinical trial on grounds of commercial sensitivity, and is introducing updated guidance on the minimum information that sponsors of such studies should still make public.